BRCA and cancer: The ‘Jewish gene’

Nana Zeligman-SommersIn the winter of 2003, Nana Zeligman-Sommers noticed she was urinating frequently and felt very tired. Attributing her fatigue to being the single parent of a teenager, she waited for the problem to clear up on its own.

Urinary frequency, coupled with pelvic or abdominal pain, bloating and having difficulty eating or feeling full right after a meal, are the four hallmark signs of ovarian cancer.

“There was no bloating, no pain,” she tells the Intermountain Jewish News. “I wasn’t worried.”

There is no test for ovarian cancer. Once detected, the disease is usually in an advanced stage.

One night Zeligman-Sommers rolled over in bed, brushed her hand against her abdomen and felt a mass.

“I made an appointment with my gynecologist for the next day. The first thing I am asked is, ‘Do you have cancer in your family?’”

Most people can rattle off their family’s medical history with ease.

However, Zeligman-Sommers is the daughter of Holocaust survivors. For her, it was the $64,000 question.

Her father, a Polish Jew, was in Auschwitz, Birkenau and Dachau. His entire family perished in the inferno, and he died of asbestos-induced mesothelioma after the war.

Her mother is of Orthodox Greek extraction. Repatriated to Germany in the Holocaust, she toiled in several work camps and converted to Judaism after marrying Zeligman-Sommers’ father.

“I told the doctor, I only know my parents’ medical history. Hitler killed my father’s family so I can’t help you there,” she says.

“No one ever mentioned that as an Ashkenazi Jewish woman I was in the highest risk category for ovarian and breast cancer.”

About 2-3% of Jews of Eastern European descent carry the harmful BRCA1 or BRCA2 mutation. This rate is about 10 times higher than the non-Jewish population.

Ashkenazi Jewish women have a higher rate of developing hereditary breast and ovarian cancer primarily due to BRCA1 and BRCA2 mutations. Family history of breast or ovarian cancer on the maternal or paternal side are significant lifetime risk factors.

The rest of this article is available in the IJN’s print edition only. Contact Carol to order your copy at (303) 861-2234 or email carol@ijn.com.

Read also the related IJN editorial, “When it comes to your health, exercise due diligence“